Cargando…

Interleukin 15 in Cell-Based Cancer Immunotherapy

Cell-based cancer immunotherapy, such as chimeric antigen receptor (CAR) engineered T and natural killer (NK) cell therapies, has become a revolutionary new pillar in cancer treatment. Interleukin 15 (IL-15), a potent immunostimulatory cytokine that potentiates T and NK cell immune responses, has de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yang, Husman, Tiffany, Cen, Xinjian, Tsao, Tasha, Brown, James, Bajpai, Aarushi, Li, Miao, Zhou, Kuangyi, Yang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266896/ https://www.ncbi.nlm.nih.gov/pubmed/35806311 http://dx.doi.org/10.3390/ijms23137311

Ejemplares similares

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering
por: Lee, Derek, et al.
Publicado: (2023)

Research progress of interleukin-15 in cancer immunotherapy
por: Cai, Menghan, et al.
Publicado: (2023)

A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy
por: Liang, Xiao, et al.
Publicado: (2016)

Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex
por: Zloza, Andrew, et al.
Publicado: (2013)

Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
por: Berger, Alexandra, et al.
Publicado: (2019)

Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
por: Xu, Xiaojing, et al.
Publicado: (2018)

Localized Interleukin-12 for Cancer Immunotherapy
por: Nguyen, Khue G., et al.
Publicado: (2020)

Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies
por: Lui, Grace, et al.
Publicado: (2023)

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model
por: Papaevangelou, Efthymia, et al.
Publicado: (2020)

Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
por: Esteves, Ana M., et al.
Publicado: (2021)

Interleukin-21 in cancer immunotherapy: Friend or foe?
por: Stolfi, Carmine, et al.
Publicado: (2012)

Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
por: Van Audenaerde, Jonas RM, et al.
Publicado: (2020)

Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival
por: Broucek, Joseph R, et al.
Publicado: (2013)

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004)

IL-15 in the Combination Immunotherapy of Cancer
por: Waldmann, Thomas A., et al.
Publicado: (2020)

Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Therapeutic potential of interleukin-15 in cancer (Review)
por: Isvoranu, Gheorghita, et al.
Publicado: (2021)

Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis
por: Vo, Jimmy LN, et al.
Publicado: (2015)

Targeting the interleukin-17 immune axis for cancer immunotherapy
por: Vitiello, Gerardo A., et al.
Publicado: (2020)

The Pleiotropic Functions of Interleukin 15: Not so Interleukin 2–Like after All
por: Ma, Averil, et al.
Publicado: (2000)

Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
por: Yang, Ying, et al.
Publicado: (2020)

Cancer Immunotherapy for Immunocompromised Patients: An Often Ignored, yet Vital Puzzle
por: Bajpai, Jyoti
Publicado: (2020)

Interleukin-15 in Outcomes of Pregnancy
por: Gordon, Scott M.
Publicado: (2021)

Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice
por: Yiang, Giou-Teng, et al.
Publicado: (2009)

The application of Interleukin-2 family cytokines in tumor immunotherapy research
por: Zhou, Yangyihua, et al.
Publicado: (2023)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment
por: Lv, Fangfang, et al.
Publicado: (2021)

Combination of interleukin-15 and fractionated radiotherapy for cancer treatment
por: Aryankalayil, Joseph, et al.
Publicado: (2014)

Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
por: Hasibuzzaman, M. M., et al.
Publicado: (2022)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Li, Yan-Ruide, et al.
Publicado: (2021)

Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
por: Lissoni, P., et al.
Publicado: (1991)

A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12
por: Klinke, David J
Publicado: (2010)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
por: Lee, Derek, et al.
Publicado: (2022)

High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy
por: He, Fei, et al.
Publicado: (2021)

Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
por: Li, Yan-Ruide, et al.
Publicado: (2021)

Localized interleukin-12 delivery for immunotherapy of solid tumours
por: Wei, Louis Z, et al.
Publicado: (2013)

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_len35df4ajti7evoftv875fj9n